Entero Healthcare Solutions Limited ENTEROshare price and chart
Entero Healthcare Solutions closed at ₹1,973.00 on 19 November 2026, down 0.65% on the day. The 52-week range is ₹944.00 to ₹2,137.60.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on ENTERO
Real prices, every charge counted. Pick one or write your own.Entero Healthcare Solutions and its subsidiaries distribute and market pharmaceuticals, surgical and other healthcare products to other businesses, which provide all of its turnover, through 137 locations across 21 states.
Retailing
Pharmaceutical and surgical product distribution
Pharmacies, hospitals, healthcare businesses
Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Retailing · 59 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 4 Nov 2026), sales rose 32.9% from a year earlier to ₹2,087 cr and profit rose 66.0% to ₹60.7 cr.
- Return on equity stayed under 10% from FY24 to FY26 (highest 8.3%).
- Foreign institutions cut their holding by 11.4 points over 5 quarters (17.20% to 5.77%).
- Domestic institutions raised their holding by 11.0 points over 5 quarters (10.18% to 21.16%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Share price reaction to resultsWhat the share price did around each recent quarterly result.
Over the last 12 results, the share rose on 6 and fell on 6, and moved by 3% or more on 8.
Q2 FY27: results filed 4 Nov 2026. The share went from its close on 3 Nov 2026 to its close on 5 Nov 2026 +10.92%.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsShareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itEach line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Pharmacy Retail. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Revenue and profit, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹2.2 as profit.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearCash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash fell by ₹83 Cr, after ₹68 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY25 | FY26 |
|---|---|---|
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 3.4% | 4.0% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 2.1% | 2.2% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 6.3% | 8.3% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 9.1% | 10.7% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.17x | 0.32x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 4.3x | 4.3x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Retailing| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| ETERNAL ETERNAL LIMITED | 3.54 L cr | 679.4x | 11.3x | 1.2% | 3.3% | 0.00 | 0.6% | +77.6% | 0.00% |
| DMART Avenue Supermarts Limited | 2.28 L cr | 73.2x | 8.8x | 12.9% | 17.2% | 0.16 | 4.2% | +17.8% | 0.00% |
| TRENT Trent Limited | 1.72 L cr | 90.7x | 22.1x | 27.1% | 35.1% | 0.06 | 8.7% | +21.9% | 0.12% |
| LENSKART Lenskart Solutions Limited | 1.29 L cr | 163.7x | 13.8x | 5.7% | 9.5% | 0.02 | 7.7% | +35.7% | 0.00% |
| MEESHO Meesho Limited | 1.20 L cr | - | 28.5x | -30.9% | -27.4% | 0.00 | -6.2% | - | 0.00% |
| NYKAA FSN E-Commerce Ventures Limited | 1.02 L cr | 319.5x | 61.9x | 14.3% | 19.6% | 0.58 | 2.9% | +28.1% | 0.00% |
| NAUKRI Info Edge (India) Limited | 75,068 cr | 42.5x | 1.6x | 4.6% | 5.6% | 0.00 | 63.7% | +12.2% | 0.98% |
| SWIGGY Swiggy Limited | 50,597 cr | - | 3.0x | -29.1% | -27.6% | 0.00 | -13.3% | +36.1% | 0.00% |
| VMM Vishal Mega Mart Limited | 43,096 cr | 47.9x | 5.5x | 12.2% | 18.8% | 0.00 | 6.5% | +14.0% | 0.00% |
| URBANCO Urban Company Limited | 27,150 cr | - | 13.7x | -10.9% | -6.1% | 0.00 | -24.4% | +41.4% | 0.00% |
| CARTRADE Cartrade Tech Limited | 12,843 cr | 54.8x | 4.9x | 9.8% | 12.2% | 0.00 | 30.8% | +10.2% | 0.00% |
| MANYAVAR Vedant Fashions Limited | 11,371 cr | 29.4x | 5.4x | 20.0% | 29.4% | 0.00 | 26.4% | +2.4% | 1.66% |
| INDIAMART Indiamart Intermesh Limited | 9,337 cr | 18.6x | 4.0x | 20.7% | 30.8% | 0.00 | 30.4% | +9.6% | 3.86% |
| ABLBL Aditya Birla Lifestyle Brands Limited | 9,305 cr | 44.9x | 6.5x | 12.1% | 26.0% | 0.86 | 2.3% | +11.2% | 0.66% |
| FIRSTCRY Brainbees Solutions Limited | 9,119 cr | - | 1.9x | -3.8% | -0.2% | 0.15 | -1.6% | +14.1% | 0.00% |
| ENTERO Entero Healthcare Solutions Limited | 8,587 cr | 61.6x | 4.8x | 8.3% | 10.7% | 0.42 | 2.5% | +32.9% | 0.00% |
| MEDPLUS Medplus Health Services Limited | 7,124 cr | 33.6x | 3.4x | 11.8% | 21.3% | 0.00 | 2.8% | +21.3% | 0.00% |
| AVL Aditya Vision Limited | 6,978 cr | 50.1x | 9.1x | 18.4% | 20.8% | 0.38 | 4.7% | +28.1% | 0.23% |
| VMART V-Mart Retail Limited | 6,189 cr | 47.3x | 6.3x | 14.1% | 22.9% | 0.19 | 3.1% | +18.1% | 0.13% |
| V2RETAIL V2 Retail Limited | 5,738 cr | 31.0x | 6.0x | 26.0% | 38.5% | 0.55 | 5.0% | +27.8% | 0.00% |
| JUSTDIAL Just Dial Limited | 5,631 cr | 11.0x | 1.1x | 10.2% | 12.9% | 0.00 | 38.3% | +13.1% | 0.00% |
| EMIL Electronics Mart India Limited | 5,325 cr | 23.1x | 3.0x | 6.8% | 11.8% | 0.39 | 2.8% | +19.4% | 0.00% |
| SSRETAIL SS Retail Limited | 4,923 cr | - | 8.0x | - | - | 0.43 | - | - | 0.00% |
| ARVINDFASN Arvind Fashions Limited | 4,876 cr | 37.3x | 5.0x | 15.8% | 26.6% | 0.56 | 3.5% | +10.0% | 0.44% |
| ABFRL Aditya Birla Fashion and Retail Limited | 4,470 cr | - | 0.9x | -12.7% | -5.1% | 0.42 | -11.0% | +2.4% | 0.00% |
| SHOPERSTOP Shoppers Stop Limited | 4,156 cr | - | 14.7x | -11.8% | 39.8% | 1.03 | -0.2% | +8.7% | 0.00% |
| STYLEBAAZA Baazar Style Retail Limited | 3,990 cr | - | 7.1x | 11.0% | 20.2% | 0.93 | -1.9% | -10.0% | 0.00% |
| PERNIASPOP Purple Style Labs Limited | 3,961 cr | - | 9.4x | - | - | 0.93 | - | - | 0.00% |
| RTNINDIA RattanIndia Enterprises Limited | 3,410 cr | - | 4.5x | -19.6% | - | 1.58 | -3.7% | -2.9% | 0.00% |
| CRIZAC Crizac Limited | 2,634 cr | 12.6x | 3.9x | 37.0% | 48.4% | 0.00 | 21.3% | -36.7% | 7.97% |
| GOCOLORS Go Fashion (India) Limited | 1,512 cr | 36.6x | 2.1x | 8.5% | 18.5% | 0.00 | 4.9% | -2.9% | 0.00% |
| KALAMANDIR Sai Silks (Kalamandir) Limited | 1,381 cr | 10.4x | 1.1x | 11.8% | 17.1% | 0.01 | 7.8% | -2.3% | 1.67% |
| ACEVECTOR AceVector Limited | 1,109 cr | - | 3.5x | - | - | 0.10 | - | - | 0.00% |
| MATRIMONY Matrimony.Com Limited | 1,077 cr | 18.8x | 4.6x | 15.3% | 21.6% | 0.00 | 11.7% | +17.6% | 0.96% |
| TCC TCC Concept Limited | 957 cr | - | 0.6x | 3.9% | 4.6% | 0.00 | - | - | 0.00% |
| PATELRMART Patel Retail Limited | 769 cr | 18.6x | 2.0x | 10.7% | 13.3% | 0.27 | 3.3% | +34.2% | 0.00% |
| MUFTI Credo Brands Marketing Limited | 488 cr | 9.4x | 1.1x | 11.2% | 21.0% | 0.00 | 8.3% | +15.6% | 2.68% |
| KORE Jay Jalaram Technologies Limited | 317 cr | 21.9x | 3.4x | - | 13.3% | 1.20 | 1.3% | +83.7% | 0.00% |
| SHANKARA Shankara Building Products Limited | 278 cr | 19.0x | 0.6x | 0.6% | 2.7% | 0.41 | 1.0% | +31.3% | 0.00% |
| MAGSON Magson Retail And Distribution Limited | 239 cr | 94.9x | 2.5x | - | 3.7% | 0.12 | 1.0% | +92.8% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.6 | -6.6 | +20.9 | -2.5 | -1.7 | -0.5 | +4.5 | +45.5 | -5.6 | -7.8 | +25.3 | · | +92.2% 11m |
| 2025 | -5.3 | -6.2 | -10.1 | +15.6 | -8.7 | -4.5 | +12.2 | -8.1 | -5.7 | -0.8 | -3.9 | -3.4 | -27.9% |
| 2024 | · | · | -8.8 | +18.6 | -12.2 | +1.1 | +15.0 | +14.4 | -0.2 | +0.9 | -1.8 | +5.3 | +31.5% 10m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2026-09-18 | HDFC MUTUAL FUND · block | BUY | 13,90,000 | ₹1,695.00 | ₹235.60 Cr |
| 2026-09-18 | HDFC MUTUAL FUND · bulk | BUY | 13,90,000 | ₹1,695.00 | ₹235.60 Cr |
| 2026-09-18 | PRASID UNO FAMILY TRUST · bulk | SELL | 12,21,820 | ₹1,695.00 | ₹207.10 Cr |
| 2026-09-18 | PRASID UNO FAMILY TRUST · block | SELL | 12,21,820 | ₹1,695.00 | ₹207.10 Cr |
| 2026-09-18 | PRASID UNOFAMILY TRUST · block | SELL | 1,68,180 | ₹1,695.00 | ₹28.51 Cr |
| 2026-09-17 | PRASID UNO FAMILY TRUST · bulk | SELL | 4,10,000 | ₹1,692.98 | ₹69.41 Cr |
| 2024-02-16 | MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED · bulk | SELL | 2,22,732 | ₹1,188.51 | ₹26.47 Cr |
| 2024-02-16 | MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED · bulk | BUY | 2,22,732 | ₹1,180.30 | ₹26.29 Cr |
- Board outcomeOutcome of Board Meeting4 Nov 2026
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting7 Aug 2026
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Board outcomeOutcome of Board Meeting25 May 2026
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting12 Feb 2026
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Board outcomeOutcome of Board Meeting12 Nov 2025
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting8 Aug 2025
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Board outcomeOutcome of Board Meeting27 May 2025
Submission of Audited Financial Results for the quarter and year ended March 31, 2025
- Integrated Filing- Financial12 Feb 2025
Integrated Filing- Financials for the Quarter ended December 31, 2024
- Financial Result Updates12 Feb 2025
Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test ENTERO. “Buy ENTERO when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free